Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2025-12-25 @ 1:39 AM
Study NCT ID:
NCT03377894
Status:
UNKNOWN
Last Update Posted:
2017-12-19
First Post:
2017-12-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Sharp Versus Blunt Uterine Incision Expansion
Sponsor:
Kasr El Aini Hospital
Organization:
Study Overview
Official Title:
Comparison Between Blunt Versus Sharp Expansion of Uterine Incision at Lower Segment Cesarean Section as Regards the Intra-operative Blood Loss & Postoperative Pain
Status:
UNKNOWN
Status Verified Date:
2017-12
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
comparison between blunt versus sharp expansion of uterine incision at lower segment cesarean section in primigravida as regards the intra-operative blood loss \& postoperative pain
Detailed Description:
the study includes 200 pregnant women, primigravidas, at term who underwent elective transverse lower segment Cesarean section for the first time among the age group of 20 - 37 years with a singleton pregnancy.
The patients are divided randomly into two groups as follows:
* Group (A): undergoing blunt uterine incision expansion
* Group (B): undergoing sharp uterine incision expansion
The patients are divided randomly into two groups as follows:
* Group (A): undergoing blunt uterine incision expansion
* Group (B): undergoing sharp uterine incision expansion
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: